Monoclonal antibody treatment highly effective at reducing COVID-19 hospitalizations
by Press Release from Outbreak News Today on (#5R8SK)
By NewsDesk @bactiman63 Researchers this week published interim results in The New England Journal of Medicine from a Phase 3 study of the COVID-19 monoclonal antibody treatment sotrovimab, sponsored by Vir Biotechnology and GlaxoSmithKline. The study found that compared to the placebo group, COVID-19 patients who received sotrovimab had a significantly reduced risk of hospitalization or death and [...]
The post Monoclonal antibody treatment highly effective at reducing COVID-19 hospitalizations appeared first on Outbreak News Today.